Legemidler

Historiske milepæler i MS-behandling

    

 

Referanser

  1. Medaer R. Does the history of multiple sclerosis go back as far as the 14th century? Acta Neurologica Scandinavica 1979; 60(3):189–92.
  2. Murray T. Robert Carswell: the first illustrator of MS. The International MS Journal 2009; 16, 98–101.
  3. Compston A, et al. McAlpine's Multiple Sclerosis (Fourth Edition) 2006. London: Churchill Livingstone. 3-6.
  4. Rolak L. MS: The Basic Facts. Clinical Medicine & Research 2003; 1(1), 61–62.
  5. Young I. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2(8255):1063-6
  6. Paterson P. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. The Journal of Experimental Medicine 1960; 111, 119–136.
  7. Fletcher J, Lalor SJ, Sweeney CM et al. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 2010; 162, 1–11.
  8. Holmøy T. The Discovery of Oligoclonal Bands: A 50-Year Anniversary. European Neurology 2009; 62, 311–315.
  9. Steinman L. Optic Neuritis, A New Variant of Experimental Encephalomyelitis, A Durable Model for All Seasons, Now In Its Seventieth Year. The Journal of Experimental Medicine 2003; 197 (9), 1065–1071.
  10. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33, 1444–52.
  11. Disanto G, Morahan JM, Barnett MH et al. The evidence for a role of B cells in multiple sclerosisNeurology 2012;78 (11), 823–32.
  12. Hauser SL, Waubant E, Arnold DL et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. New England Journal of Medicine 2008;358, 676–88.

 

NO/OCRE/1806/0026